All your efforts and focus on discovery and preclinical work are finally coming to a successful culmination, and now you need to quickly move into clinical...

Here we explore a case study on optimizing and scaling up a plasmid DNA process. Our Fast Trak™ process development services team used design of experiment...

The number of monoclonal antibodies (mAbs) with high-concentration formulation is expected to grow annually by 13% between 2024 and 2029. Meeting this dema...

Due to the high cost and complexity of using real viruses in process development, virus clearance is traditionally tested only in phase 1 and 3 clinical tr...

In silico chromatography process development with the GoSilico™ chromatography modeling software can speed up PD work and simultaneously improve process un...

Using modeling during process development can improve efficiency. In this presentation we discuss the benefits and considerations for process development s...

In this presentation you will learn about how ÄKTA™ avant chromatography system can be used to design in buffer formulations to be used in large scale inli...

In this presentation we describe and evaluate various strategies for the monoclonal antibody (mAb) capture step. We look at factors to consider when choosi...

The US FDA considers buffers as crucial raw materials in the production of active pharmaceutical ingredients (APIs) or intermediates from cell culture or f...

Trace metals in complex cell culture media (CCM) can have a significant impact on critical quality attributes of recombinant therapeutic proteins. Raw mate...